T1	ANAT 930 944	leptomeningeas
#1	AnnotatorNotes T1	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T2	CHEM 108 117	nivolumab
#2	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 120 131	daratumumab
#3	AnnotatorNotes T3	C2346801; daratumumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 157 168	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 172 187	tumores sólidos
#5	AnnotatorNotes T5	C0280100; Solid Neoplasm; Neoplastic Process
T6	PROC 235 250	Ensayo fase 1/2
T7	PROC 256 290	evaluar la seguridad y la eficacia
#6	AnnotatorNotes T7	C0511730; Identify product efficacy and safety issues; Health Care Activity
T8	CHEM 305 314	nivolumab
#7	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	CHEM 329 340	daratumumab
#8	AnnotatorNotes T9	C2346801; daratumumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	DISO 390 402	metastásicos
#9	AnnotatorNotes T10	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T11	DISO 426 434	Cánceres
#10	AnnotatorNotes T11	C0006826; Malignant Neoplasms; Neoplastic Process
T12	DISO 471 486	Tumores sólidos
#11	AnnotatorNotes T12	C0280100; Solid Neoplasm; Neoplastic Process
T13	DISO 554 569	tumores sólidos
#12	AnnotatorNotes T13	C0280100; Solid Neoplasm; Neoplastic Process
T14	DISO 609 642	carcinoma de mama triple negativo
#13	AnnotatorNotes T14	C4722518; Triple-Negative Breast Carcinoma; Neoplastic Process
T15	DISO 362 377	tumores sólidos
#14	AnnotatorNotes T15	C0280100; Solid Neoplasm; Neoplastic Process
T16	DISO 704 730	adenocarcinoma pancreático
T17	DISO 1015 1025	malignidad
#15	AnnotatorNotes T17	C0006826; Malignant Neoplasms; Neoplastic Process
T18	DISO 831 862	Cáncer de pulmón no microcítico
#16	AnnotatorNotes T18	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T19	DISO 864 868	CPNM
#17	AnnotatorNotes T19	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T20	DISO 898 944	Metástasis cerebrales activas o leptomeningeas
T21	DISO 958 975	alteración médica
T22	DISO 200 212	metastásicos
#18	AnnotatorNotes T22	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T23	DISO 499 511	metastásicos
#19	AnnotatorNotes T23	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T24	DISO 582 594	metastásicos
#20	AnnotatorNotes T24	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T25	ANAT 622 626	mama
#21	AnnotatorNotes T25	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T26	ANAT 719 730	pancreático
#22	AnnotatorNotes T26	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T27	ANAT 841 847	pulmón
#23	AnnotatorNotes T27	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T28	ANAT 851 862	microcítico
#24	AnnotatorNotes T28	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T29	ANAT 909 919	cerebrales
#25	AnnotatorNotes T29	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T30	Date 13 17	2017
T32	LIVB 540 549	Pacientes
#26	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 597 604	Mujeres
#27	AnnotatorNotes T33	C0043210; Woman; Population Group
T35	LIVB 765 774	pacientes
#28	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Neg_cue 848 850	no
T38	Duration 1043 1064	los 3 años anteriores
T31	LIVB 344 357	participantes
#29	AnnotatorNotes T31	C4554048; Study Participant; Population Group
T34	LIVB 686 699	Participantes
#30	AnnotatorNotes T34	C4554048; Study Participant; Population Group
T37	PROC 731 747	histológicamente
#31	AnnotatorNotes T37	C0344441; Histology Procedure; Laboratory Procedure
T39	PROC 654 683	citológica o histológicamente
#32	AnnotatorNotes T39	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
T40	PROC 790 827	confirmación histológica o citológica
#33	AnnotatorNotes T40	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T28 Negated
#34	AnnotatorNotes T6	C1519043; Phase I/II Trial; Research Activity
#35	AnnotatorNotes T16	C0281361; Adenocarcinoma of pancreas; Neoplastic Process | C0346647; Malignant neoplasm of pancreas; Neoplastic Process
T41	Neg_cue 984 986	no
T42	Quantifier_or_Qualifier 987 997	controlada
A2	Assertion T42 Negated
T43	Spec_cue 87 89	si
R1	Combined_with Arg1:T2 Arg2:T3	
T44	Quantifier_or_Qualifier 135 141	segura
A3	Assertion T44 Speculated
R2	Speculation Arg1:T43 Arg2:T44	
T45	Quantifier_or_Qualifier 144 150	eficaz
A4	Assertion T45 Speculated
#36	AnnotatorNotes T45	C1704419; Effective; Qualitative Concept
R3	Speculation Arg1:T43 Arg2:T45	
R4	Used_for Arg1:T2 Arg2:T4	
R5	Before Arg1:T5 Arg2:T22	
T46	Quantifier_or_Qualifier 188 197	avanzados
#37	AnnotatorNotes T46	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R6	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T46	
T47	Quantifier_or_Qualifier 378 387	avanzados
#38	AnnotatorNotes T47	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R7	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T47	
R8	Before Arg1:T15 Arg2:T10	
R9	Before Arg1:T12 Arg2:T23	
T48	Quantifier_or_Qualifier 487 496	avanzados
#39	AnnotatorNotes T48	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R10	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T48	
T49	Quantifier_or_Qualifier 435 444	avanzados
#40	AnnotatorNotes T49	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R11	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T49	
R12	Before Arg1:T13 Arg2:T24	
T50	Quantifier_or_Qualifier 570 579	avanzados
#41	AnnotatorNotes T50	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R13	Experiences Arg1:T32 Arg2:T13	
R14	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T50	
R15	Experiences Arg1:T32 Arg2:T24	
R16	Location_of Arg1:T25 Arg2:T14	
R18	Experiences Arg1:T33 Arg2:T14	
R19	Experiences Arg1:T34 Arg2:T16	
R20	Location_of Arg1:T26 Arg2:T16	
R22	Experiences Arg1:T35 Arg2:T40	
R23	Experiences Arg1:T35 Arg2:T18	
R24	Experiences Arg1:T35 Arg2:T19	
R25	Location_of Arg1:T28 Arg2:T18	
R26	Location_of Arg1:T27 Arg2:T18	
R27	Negation Arg1:T36 Arg2:T28	
R28	Location_of Arg1:T28 Arg2:T19	
R29	Location_of Arg1:T27 Arg2:T19	
R32	Location_of Arg1:T29 Arg2:T20	
R33	Location_of Arg1:T1 Arg2:T20	
R34	Negation Arg1:T41 Arg2:T42	
R35	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T42	
T51	Quantifier_or_Qualifier 976 981	grave
#42	AnnotatorNotes T51	C1547227; Severe - Severity of Illness Code; Intellectual Product
R36	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T51	
R37	Overlap Arg1:T17 Arg2:T38	
T52	Quantifier_or_Qualifier 1026 1032	activa
#43	AnnotatorNotes T52	C0679217; Active State; Idea or Concept
R38	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T52	
R39	Combined_with Arg1:T8 Arg2:T9	
R40	Experiences Arg1:T31 Arg2:T8	
R41	Experiences Arg1:T31 Arg2:T15	
R42	Experiences Arg1:T31 Arg2:T10	
R43	Experiences Arg1:T33 Arg2:T39	
R44	Experiences Arg1:T34 Arg2:T37	
#44	AnnotatorNotes T21	C4745084; Medical Condition; Finding (?) 
A5	Experiencer T31 Patient
A6	Experiencer T32 Patient
A7	Experiencer T33 Patient
A8	Experiencer T34 Patient
A9	Experiencer T35 Patient
